Sabby Management’s Tempest Therapeutics TPST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
– Hold
0
– -$489K – 352
2015
Q4
– Hold
0
– – – 237
2015
Q3
– Sell
-1
Closed -$67.3K – 280
2015
Q2
$6.36M Buy
+1
New +$91.6K 0.23% 80
2015
Q1
– Hold
0
– – – 104

Other funds holding TPST

Sabby Management's TPST Position: Q3 2026 in Review

Sabby Management sold out of Tempest Therapeutics (TPST) in Q3 2026, closing a stake of 511,286 shares — an estimated $568K sold.

Sabby Management first reported a position in TPST in Q3 2013 and held it in 21 quarters. The position peaked at $10.3M in Q2 2015. 24 funds tracked by Wall St. Rank hold TPST as of Q3 2026.

  • Sabby Management reported no remaining Tempest Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Sabby Management sold 511,286 Tempest Therapeutics shares in Q3 2026, an estimated $568K.
  • Sabby Management first reported a position in Tempest Therapeutics in Q3 2013 and held it in 21 quarters.
  • Sabby Management's Tempest Therapeutics position peaked at $10.3M in Q2 2015.
  • 24 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q3 2026.

Based on Sabby Management's 13F filing for Q3 2026, filed 13 Nov 2026.